Trial intelligence / Profile preview

Erythropoietin versus placebo in diabetic neuropathy (IV, pilot, randomized double-blind)

2005-001501-26Phase 2Terminated

Sponsor
Carlo Besta Neurological Institute
Start
Nov 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in diabetic neuropathy comparing Erythropoietin IV with Placebo IV (2 arms). Started Nov 2005; status: terminated.

02

Drugs

erythropoietin
03

Conditions

diabetic neuropathy

Beyond the preview

Go deeper on 2005-001501-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001501-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call